NLS Pharmaceutics (NLS Pharmaceutics) Institutional Ownership : 0.26% (As of Jun. 07, 2024)

View and export this data going back to 2021. Start your Free Trial

What is NLS Pharmaceutics Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NLS Pharmaceutics's institutional ownership is 0.26%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NLS Pharmaceutics's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NLS Pharmaceutics's Float Percentage Of Total Shares Outstanding is 61.24%.

NLS Pharmaceutics Institutional Ownership Historical Data

The historical data trend for NLS Pharmaceutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NLS Pharmaceutics Institutional Ownership Chart

NLS Pharmaceutics Historical Data

The historical data trend for NLS Pharmaceutics can be seen below:

	2023-08-31	2023-09-30	2023-10-31	2023-11-30	2023-12-31	2024-01-31	2024-02-29	2024-03-31	2024-04-30	2024-05-31
Institutional Ownership	0.32	0.32	0.32	0.32	0.32	0.32	0.35	0.26	0.26	0.26

NLS Pharmaceutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

NLS Pharmaceutics (NLS Pharmaceutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NLS Pharmaceutics Ltd (NAS:NLSP) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

N/A

Address

The Circle 6, Zurich, CHE, 8058

Website

https://www.nlspharma.com

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.